nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Temozolomide—malignant glioma	0.352	1	CbGbCtD
Etonogestrel—Fibrosis—Carmustine—malignant glioma	0.0202	0.0514	CcSEcCtD
Etonogestrel—Influenza-like symptoms—Temozolomide—malignant glioma	0.00781	0.0199	CcSEcCtD
Etonogestrel—Menorrhagia—Temozolomide—malignant glioma	0.00753	0.0192	CcSEcCtD
Etonogestrel—Abscess—Carmustine—malignant glioma	0.00729	0.0186	CcSEcCtD
Etonogestrel—Otitis media—Temozolomide—malignant glioma	0.00716	0.0182	CcSEcCtD
Etonogestrel—Injection site pain—Carmustine—malignant glioma	0.00707	0.018	CcSEcCtD
Etonogestrel—Breast pain—Temozolomide—malignant glioma	0.00639	0.0163	CcSEcCtD
Etonogestrel—Amenorrhoea—Temozolomide—malignant glioma	0.00635	0.0162	CcSEcCtD
Etonogestrel—Herpes simplex—Temozolomide—malignant glioma	0.00605	0.0154	CcSEcCtD
Etonogestrel—Injection site reaction—Carmustine—malignant glioma	0.00574	0.0146	CcSEcCtD
Etonogestrel—Musculoskeletal pain—Temozolomide—malignant glioma	0.00564	0.0144	CcSEcCtD
Etonogestrel—Vaginal inflammation—Temozolomide—malignant glioma	0.00558	0.0142	CcSEcCtD
Etonogestrel—Influenza like illness—Temozolomide—malignant glioma	0.00541	0.0138	CcSEcCtD
Etonogestrel—Vaginal infection—Temozolomide—malignant glioma	0.00526	0.0134	CcSEcCtD
Etonogestrel—Neoplasm—Carmustine—malignant glioma	0.00522	0.0133	CcSEcCtD
Etonogestrel—Neoplasm—Temozolomide—malignant glioma	0.00504	0.0128	CcSEcCtD
Etonogestrel—Abnormal vision—Carmustine—malignant glioma	0.00503	0.0128	CcSEcCtD
Etonogestrel—Abnormal vision—Temozolomide—malignant glioma	0.00486	0.0124	CcSEcCtD
Etonogestrel—Swelling—Carmustine—malignant glioma	0.00475	0.0121	CcSEcCtD
Etonogestrel—Hot flush—Temozolomide—malignant glioma	0.00433	0.011	CcSEcCtD
Etonogestrel—Menopausal symptoms—Temozolomide—malignant glioma	0.00429	0.0109	CcSEcCtD
Etonogestrel—Affect lability—Temozolomide—malignant glioma	0.00398	0.0101	CcSEcCtD
Etonogestrel—Mood swings—Temozolomide—malignant glioma	0.00383	0.00976	CcSEcCtD
Etonogestrel—Breast disorder—Temozolomide—malignant glioma	0.00366	0.00931	CcSEcCtD
Etonogestrel—Abdominal distension—Temozolomide—malignant glioma	0.00352	0.00897	CcSEcCtD
Etonogestrel—Bronchitis—Temozolomide—malignant glioma	0.00336	0.00857	CcSEcCtD
Etonogestrel—Dysuria—Temozolomide—malignant glioma	0.00327	0.00833	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00325	0.00828	CcSEcCtD
Etonogestrel—Pollakiuria—Temozolomide—malignant glioma	0.00323	0.00823	CcSEcCtD
Etonogestrel—Depression—Carmustine—malignant glioma	0.00322	0.00819	CcSEcCtD
Etonogestrel—Weight increased—Temozolomide—malignant glioma	0.00318	0.00811	CcSEcCtD
Etonogestrel—Weight decreased—Temozolomide—malignant glioma	0.00316	0.00806	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Carmustine—malignant glioma	0.00316	0.00806	CcSEcCtD
Etonogestrel—Urinary tract infection—Carmustine—malignant glioma	0.00314	0.00799	CcSEcCtD
Etonogestrel—Infestation NOS—Temozolomide—malignant glioma	0.00312	0.00794	CcSEcCtD
Etonogestrel—Infestation—Temozolomide—malignant glioma	0.00312	0.00794	CcSEcCtD
Etonogestrel—Depression—Temozolomide—malignant glioma	0.00311	0.00792	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Temozolomide—malignant glioma	0.00306	0.00778	CcSEcCtD
Etonogestrel—Urinary tract infection—Temozolomide—malignant glioma	0.00303	0.00772	CcSEcCtD
Etonogestrel—Sinusitis—Temozolomide—malignant glioma	0.00293	0.00745	CcSEcCtD
Etonogestrel—Haemoglobin—Carmustine—malignant glioma	0.00291	0.00742	CcSEcCtD
Etonogestrel—Haemorrhage—Carmustine—malignant glioma	0.0029	0.00738	CcSEcCtD
Etonogestrel—Hypoaesthesia—Carmustine—malignant glioma	0.00288	0.00734	CcSEcCtD
Etonogestrel—Connective tissue disorder—Carmustine—malignant glioma	0.00285	0.00725	CcSEcCtD
Etonogestrel—Haemoglobin—Temozolomide—malignant glioma	0.00281	0.00717	CcSEcCtD
Etonogestrel—Haemorrhage—Temozolomide—malignant glioma	0.0028	0.00713	CcSEcCtD
Etonogestrel—Visual impairment—Carmustine—malignant glioma	0.00279	0.00711	CcSEcCtD
Etonogestrel—Hypoaesthesia—Temozolomide—malignant glioma	0.00279	0.00709	CcSEcCtD
Etonogestrel—Pharyngitis—Temozolomide—malignant glioma	0.00278	0.00708	CcSEcCtD
Etonogestrel—Urinary tract disorder—Temozolomide—malignant glioma	0.00276	0.00704	CcSEcCtD
Etonogestrel—Connective tissue disorder—Temozolomide—malignant glioma	0.00275	0.00701	CcSEcCtD
Etonogestrel—Urethral disorder—Temozolomide—malignant glioma	0.00274	0.00699	CcSEcCtD
Etonogestrel—Eye disorder—Carmustine—malignant glioma	0.00271	0.00689	CcSEcCtD
Etonogestrel—Visual impairment—Temozolomide—malignant glioma	0.0027	0.00687	CcSEcCtD
Etonogestrel—Eye disorder—Temozolomide—malignant glioma	0.00262	0.00666	CcSEcCtD
Etonogestrel—Alopecia—Carmustine—malignant glioma	0.00256	0.00652	CcSEcCtD
Etonogestrel—Angiopathy—Temozolomide—malignant glioma	0.00254	0.00647	CcSEcCtD
Etonogestrel—Mental disorder—Carmustine—malignant glioma	0.00254	0.00646	CcSEcCtD
Etonogestrel—Immune system disorder—Temozolomide—malignant glioma	0.00253	0.00644	CcSEcCtD
Etonogestrel—Erythema—Carmustine—malignant glioma	0.00252	0.00642	CcSEcCtD
Etonogestrel—Malnutrition—Carmustine—malignant glioma	0.00252	0.00642	CcSEcCtD
Etonogestrel—Alopecia—Temozolomide—malignant glioma	0.00247	0.0063	CcSEcCtD
Etonogestrel—Mental disorder—Temozolomide—malignant glioma	0.00245	0.00625	CcSEcCtD
Etonogestrel—Back pain—Carmustine—malignant glioma	0.00244	0.00621	CcSEcCtD
Etonogestrel—Malnutrition—Temozolomide—malignant glioma	0.00244	0.00621	CcSEcCtD
Etonogestrel—Erythema—Temozolomide—malignant glioma	0.00244	0.00621	CcSEcCtD
Etonogestrel—Back pain—Temozolomide—malignant glioma	0.00236	0.006	CcSEcCtD
Etonogestrel—Ill-defined disorder—Temozolomide—malignant glioma	0.00226	0.00576	CcSEcCtD
Etonogestrel—Angioedema—Temozolomide—malignant glioma	0.00223	0.00567	CcSEcCtD
Etonogestrel—Malaise—Temozolomide—malignant glioma	0.0022	0.0056	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—CYP2B6—malignant glioma	0.00219	0.409	CrCbGaD
Etonogestrel—Convulsion—Carmustine—malignant glioma	0.00219	0.00556	CcSEcCtD
Etonogestrel—Hypertension—Carmustine—malignant glioma	0.00218	0.00554	CcSEcCtD
Etonogestrel—Myalgia—Carmustine—malignant glioma	0.00215	0.00547	CcSEcCtD
Etonogestrel—Anxiety—Carmustine—malignant glioma	0.00214	0.00545	CcSEcCtD
Etonogestrel—Cough—Temozolomide—malignant glioma	0.00213	0.00542	CcSEcCtD
Etonogestrel—Convulsion—Temozolomide—malignant glioma	0.00211	0.00538	CcSEcCtD
Etonogestrel—Hypertension—Temozolomide—malignant glioma	0.0021	0.00536	CcSEcCtD
Etonogestrel—Arthralgia—Temozolomide—malignant glioma	0.00207	0.00528	CcSEcCtD
Etonogestrel—Myalgia—Temozolomide—malignant glioma	0.00207	0.00528	CcSEcCtD
Etonogestrel—Anxiety—Temozolomide—malignant glioma	0.00207	0.00527	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00206	0.00525	CcSEcCtD
Etonogestrel—Oedema—Carmustine—malignant glioma	0.00206	0.00524	CcSEcCtD
Etonogestrel—Discomfort—Temozolomide—malignant glioma	0.00205	0.00522	CcSEcCtD
Etonogestrel—Infection—Carmustine—malignant glioma	0.00204	0.00521	CcSEcCtD
Etonogestrel—Methyltestosterone—CYP2B6—malignant glioma	0.002	0.374	CrCbGaD
Etonogestrel—Anaphylactic shock—Temozolomide—malignant glioma	0.00199	0.00507	CcSEcCtD
Etonogestrel—Oedema—Temozolomide—malignant glioma	0.00199	0.00507	CcSEcCtD
Etonogestrel—Infection—Temozolomide—malignant glioma	0.00198	0.00503	CcSEcCtD
Etonogestrel—Anorexia—Carmustine—malignant glioma	0.00196	0.005	CcSEcCtD
Etonogestrel—Nervous system disorder—Temozolomide—malignant glioma	0.00195	0.00497	CcSEcCtD
Etonogestrel—Skin disorder—Temozolomide—malignant glioma	0.00193	0.00492	CcSEcCtD
Etonogestrel—Anorexia—Temozolomide—malignant glioma	0.0019	0.00483	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00188	0.00478	CcSEcCtD
Etonogestrel—Insomnia—Carmustine—malignant glioma	0.00186	0.00474	CcSEcCtD
Etonogestrel—Paraesthesia—Carmustine—malignant glioma	0.00185	0.00471	CcSEcCtD
Etonogestrel—Somnolence—Carmustine—malignant glioma	0.00183	0.00466	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00181	0.00461	CcSEcCtD
Etonogestrel—Insomnia—Temozolomide—malignant glioma	0.0018	0.00458	CcSEcCtD
Etonogestrel—Decreased appetite—Carmustine—malignant glioma	0.00179	0.00456	CcSEcCtD
Etonogestrel—Paraesthesia—Temozolomide—malignant glioma	0.00179	0.00455	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Carmustine—malignant glioma	0.00178	0.00453	CcSEcCtD
Etonogestrel—Somnolence—Temozolomide—malignant glioma	0.00177	0.0045	CcSEcCtD
Etonogestrel—Constipation—Carmustine—malignant glioma	0.00176	0.00448	CcSEcCtD
Etonogestrel—Pain—Carmustine—malignant glioma	0.00176	0.00448	CcSEcCtD
Etonogestrel—Dyspepsia—Temozolomide—malignant glioma	0.00175	0.00446	CcSEcCtD
Etonogestrel—Decreased appetite—Temozolomide—malignant glioma	0.00173	0.0044	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00172	0.00437	CcSEcCtD
Etonogestrel—Fatigue—Temozolomide—malignant glioma	0.00171	0.00437	CcSEcCtD
Etonogestrel—Pain—Temozolomide—malignant glioma	0.0017	0.00433	CcSEcCtD
Etonogestrel—Constipation—Temozolomide—malignant glioma	0.0017	0.00433	CcSEcCtD
Etonogestrel—Feeling abnormal—Carmustine—malignant glioma	0.0017	0.00432	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Carmustine—malignant glioma	0.00168	0.00429	CcSEcCtD
Etonogestrel—Feeling abnormal—Temozolomide—malignant glioma	0.00164	0.00417	CcSEcCtD
Etonogestrel—Abdominal pain—Carmustine—malignant glioma	0.00163	0.00414	CcSEcCtD
Etonogestrel—Body temperature increased—Carmustine—malignant glioma	0.00163	0.00414	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Temozolomide—malignant glioma	0.00163	0.00414	CcSEcCtD
Etonogestrel—Urticaria—Temozolomide—malignant glioma	0.00158	0.00402	CcSEcCtD
Etonogestrel—Body temperature increased—Temozolomide—malignant glioma	0.00157	0.004	CcSEcCtD
Etonogestrel—Abdominal pain—Temozolomide—malignant glioma	0.00157	0.004	CcSEcCtD
Etonogestrel—Hypersensitivity—Carmustine—malignant glioma	0.00152	0.00386	CcSEcCtD
Etonogestrel—Asthenia—Carmustine—malignant glioma	0.00148	0.00376	CcSEcCtD
Etonogestrel—Hypersensitivity—Temozolomide—malignant glioma	0.00147	0.00373	CcSEcCtD
Etonogestrel—Asthenia—Temozolomide—malignant glioma	0.00143	0.00363	CcSEcCtD
Etonogestrel—Diarrhoea—Carmustine—malignant glioma	0.00141	0.00359	CcSEcCtD
Etonogestrel—Pruritus—Temozolomide—malignant glioma	0.00141	0.00358	CcSEcCtD
Etonogestrel—Dizziness—Carmustine—malignant glioma	0.00136	0.00347	CcSEcCtD
Etonogestrel—Diarrhoea—Temozolomide—malignant glioma	0.00136	0.00347	CcSEcCtD
Etonogestrel—Dizziness—Temozolomide—malignant glioma	0.00132	0.00335	CcSEcCtD
Etonogestrel—Vomiting—Carmustine—malignant glioma	0.00131	0.00333	CcSEcCtD
Etonogestrel—Rash—Carmustine—malignant glioma	0.0013	0.0033	CcSEcCtD
Etonogestrel—Dermatitis—Carmustine—malignant glioma	0.0013	0.0033	CcSEcCtD
Etonogestrel—Headache—Carmustine—malignant glioma	0.00129	0.00328	CcSEcCtD
Etonogestrel—Vomiting—Temozolomide—malignant glioma	0.00126	0.00322	CcSEcCtD
Etonogestrel—Rash—Temozolomide—malignant glioma	0.00125	0.00319	CcSEcCtD
Etonogestrel—Dermatitis—Temozolomide—malignant glioma	0.00125	0.00319	CcSEcCtD
Etonogestrel—Headache—Temozolomide—malignant glioma	0.00125	0.00317	CcSEcCtD
Etonogestrel—Nausea—Carmustine—malignant glioma	0.00122	0.00311	CcSEcCtD
Etonogestrel—Nausea—Temozolomide—malignant glioma	0.00118	0.00301	CcSEcCtD
Etonogestrel—Testosterone—CYP2B6—malignant glioma	0.00116	0.217	CrCbGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000423	0.00169	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—malignant glioma	0.000411	0.00164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT2—malignant glioma	0.00041	0.00164	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000408	0.00163	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000399	0.00159	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—DNMT3B—malignant glioma	0.000397	0.00159	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CD—malignant glioma	0.000394	0.00157	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000393	0.00157	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—malignant glioma	0.000388	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HIST1H3B—malignant glioma	0.000386	0.00154	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000385	0.00154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—FGF2—malignant glioma	0.000377	0.00151	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—malignant glioma	0.000376	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000373	0.00149	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MDK—malignant glioma	0.000373	0.00149	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000369	0.00147	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00036	0.00144	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—malignant glioma	0.000356	0.00143	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DTX1—malignant glioma	0.000356	0.00142	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000355	0.00142	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MDM2—malignant glioma	0.000353	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—RAF1—malignant glioma	0.000351	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB2—malignant glioma	0.000348	0.00139	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000346	0.00138	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CB—malignant glioma	0.000343	0.00137	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000341	0.00136	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000341	0.00136	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—malignant glioma	0.000325	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LATS1—malignant glioma	0.000324	0.0013	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000323	0.00129	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000317	0.00127	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000314	0.00126	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000306	0.00122	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—malignant glioma	0.000305	0.00122	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—malignant glioma	0.000301	0.0012	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000299	0.0012	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—H3F3A—malignant glioma	0.000298	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000298	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000298	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PTEN—malignant glioma	0.000297	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000294	0.00117	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000293	0.00117	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—malignant glioma	0.000291	0.00116	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00029	0.00116	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000283	0.00113	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000283	0.00113	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SUFU—malignant glioma	0.000282	0.00113	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH3—malignant glioma	0.00028	0.00112	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.00028	0.00112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HEY2—malignant glioma	0.000279	0.00112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GFAP—malignant glioma	0.000273	0.00109	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000269	0.00108	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPHK1—malignant glioma	0.000264	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000263	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000263	0.00105	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000262	0.00105	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR4—malignant glioma	0.000258	0.00103	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HEY1—malignant glioma	0.000258	0.00103	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH2—malignant glioma	0.000251	0.001	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIST1H3B—malignant glioma	0.000251	0.001	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NCOR1—malignant glioma	0.00025	0.000998	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000248	0.000991	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000247	0.000988	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000242	0.000969	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—malignant glioma	0.000241	0.000964	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—DNMT3B—malignant glioma	0.000233	0.000933	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAG2—malignant glioma	0.000229	0.000916	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000229	0.000915	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—malignant glioma	0.000228	0.00091	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HIST1H3B—malignant glioma	0.000227	0.000906	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000223	0.000892	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MDK—malignant glioma	0.000219	0.000875	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CDKN2B—malignant glioma	0.000216	0.000863	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—malignant glioma	0.000209	0.000836	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DTX1—malignant glioma	0.000209	0.000835	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000205	0.000821	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NCOR1—malignant glioma	0.000205	0.000819	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000203	0.000814	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000201	0.000803	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000196	0.000784	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—H3F3A—malignant glioma	0.000194	0.000775	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000194	0.000775	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCR3—malignant glioma	0.000192	0.000768	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000191	0.000765	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000191	0.000764	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00019	0.000758	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000189	0.000758	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—YWHAE—malignant glioma	0.000187	0.000747	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NTRK2—malignant glioma	0.000187	0.000747	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FLT1—malignant glioma	0.000186	0.000744	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DUSP6—malignant glioma	0.000185	0.00074	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAG1—malignant glioma	0.000183	0.000731	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH3—malignant glioma	0.000182	0.000728	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FBXW7—malignant glioma	0.000179	0.000716	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—malignant glioma	0.000179	0.000715	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BDKRB2—malignant glioma	0.000176	0.000702	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—H3F3A—malignant glioma	0.000175	0.0007	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000174	0.000697	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—malignant glioma	0.000174	0.000695	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000172	0.000687	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—malignant glioma	0.000171	0.000683	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000169	0.000674	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SUFU—malignant glioma	0.000166	0.000663	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH3—malignant glioma	0.000164	0.000657	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HEY2—malignant glioma	0.000164	0.000655	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH2—malignant glioma	0.000163	0.000653	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GFAP—malignant glioma	0.00016	0.00064	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KNG1—malignant glioma	0.00016	0.000639	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH1—malignant glioma	0.000155	0.000622	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPHK1—malignant glioma	0.000155	0.000619	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NTRK1—malignant glioma	0.000152	0.000609	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HEY1—malignant glioma	0.000152	0.000606	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR4—malignant glioma	0.000152	0.000606	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH2—malignant glioma	0.000147	0.000589	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000147	0.000589	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—malignant glioma	0.000147	0.000587	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000142	0.000569	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP3—malignant glioma	0.000142	0.000566	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—malignant glioma	0.00014	0.000561	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTK2—malignant glioma	0.000136	0.000545	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAG2—malignant glioma	0.000134	0.000538	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HES1—malignant glioma	0.000134	0.000535	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NCOR1—malignant glioma	0.000133	0.000532	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFRA—malignant glioma	0.000127	0.00051	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—malignant glioma	0.000127	0.000507	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPP1—malignant glioma	0.000124	0.000495	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NCOR1—malignant glioma	0.00012	0.00048	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TERT—malignant glioma	0.000117	0.000469	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFB—malignant glioma	0.000114	0.000458	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR1—malignant glioma	0.000114	0.000455	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—H3F3A—malignant glioma	0.000114	0.000455	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR3—malignant glioma	0.000113	0.000451	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—COX8A—malignant glioma	0.000113	0.00045	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—malignant glioma	0.000112	0.000449	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—YWHAE—malignant glioma	0.00011	0.000438	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NTRK2—malignant glioma	0.00011	0.000438	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FLT1—malignant glioma	0.000109	0.000436	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DUSP6—malignant glioma	0.000109	0.000435	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CAV1—malignant glioma	0.000109	0.000434	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAG1—malignant glioma	0.000107	0.000429	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—malignant glioma	0.000107	0.000429	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH3—malignant glioma	0.000107	0.000427	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FBXW7—malignant glioma	0.000105	0.00042	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—F2—malignant glioma	0.000103	0.000413	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FN1—malignant glioma	0.000103	0.000413	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BDKRB2—malignant glioma	0.000103	0.000412	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BAD—malignant glioma	0.000102	0.000408	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—malignant glioma	0.000102	0.000408	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH1—malignant glioma	0.000101	0.000404	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD80—malignant glioma	9.9e-05	0.000396	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—malignant glioma	9.88e-05	0.000395	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—malignant glioma	9.88e-05	0.000395	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGF—malignant glioma	9.77e-05	0.000391	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTPN11—malignant glioma	9.71e-05	0.000388	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH2—malignant glioma	9.58e-05	0.000383	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ASMT—malignant glioma	9.57e-05	0.000383	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KNG1—malignant glioma	9.38e-05	0.000375	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—malignant glioma	9.29e-05	0.000372	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH1—malignant glioma	9.12e-05	0.000365	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT2—malignant glioma	9.04e-05	0.000362	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BCAN—malignant glioma	9e-05	0.00036	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NTRK1—malignant glioma	8.94e-05	0.000357	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CD—malignant glioma	8.69e-05	0.000347	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—malignant glioma	8.61e-05	0.000344	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—malignant glioma	8.36e-05	0.000334	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF2—malignant glioma	8.32e-05	0.000333	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP3—malignant glioma	8.31e-05	0.000332	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—malignant glioma	8.24e-05	0.000329	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTK2—malignant glioma	8e-05	0.00032	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HES1—malignant glioma	7.86e-05	0.000314	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NCOR1—malignant glioma	7.81e-05	0.000312	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MDM2—malignant glioma	7.78e-05	0.000311	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAF1—malignant glioma	7.76e-05	0.00031	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—malignant glioma	7.67e-05	0.000307	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CB—malignant glioma	7.57e-05	0.000303	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRA—malignant glioma	7.48e-05	0.000299	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—malignant glioma	7.28e-05	0.000291	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPP1—malignant glioma	7.26e-05	0.00029	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—IDH2—malignant glioma	7.25e-05	0.00029	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—malignant glioma	6.97e-05	0.000279	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—malignant glioma	6.96e-05	0.000278	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—malignant glioma	6.88e-05	0.000275	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.82e-05	0.000273	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFB—malignant glioma	6.72e-05	0.000269	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR1—malignant glioma	6.68e-05	0.000267	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—malignant glioma	6.58e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—malignant glioma	6.58e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—malignant glioma	6.54e-05	0.000262	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CAV1—malignant glioma	6.37e-05	0.000255	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—malignant glioma	6.3e-05	0.000252	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—IDH1—malignant glioma	6.24e-05	0.000249	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—F2—malignant glioma	6.06e-05	0.000242	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FN1—malignant glioma	6.06e-05	0.000242	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SPHK1—malignant glioma	6.03e-05	0.000241	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BAD—malignant glioma	5.99e-05	0.00024	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH1—malignant glioma	5.93e-05	0.000237	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.91e-05	0.000236	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—malignant glioma	5.91e-05	0.000236	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—malignant glioma	5.85e-05	0.000234	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD80—malignant glioma	5.81e-05	0.000232	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—malignant glioma	5.8e-05	0.000232	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—malignant glioma	5.8e-05	0.000232	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—malignant glioma	5.8e-05	0.000232	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGF—malignant glioma	5.73e-05	0.000229	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTPN11—malignant glioma	5.7e-05	0.000228	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—malignant glioma	5.45e-05	0.000218	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—malignant glioma	5.44e-05	0.000217	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—malignant glioma	5.32e-05	0.000213	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT2—malignant glioma	5.31e-05	0.000212	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CD—malignant glioma	5.1e-05	0.000204	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—malignant glioma	5.02e-05	0.000201	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—malignant glioma	4.91e-05	0.000196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF2—malignant glioma	4.88e-05	0.000195	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—malignant glioma	4.78e-05	0.000191	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—malignant glioma	4.62e-05	0.000185	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MDM2—malignant glioma	4.57e-05	0.000183	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAF1—malignant glioma	4.55e-05	0.000182	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—malignant glioma	4.5e-05	0.00018	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS1—malignant glioma	4.48e-05	0.000179	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—malignant glioma	4.47e-05	0.000179	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CB—malignant glioma	4.44e-05	0.000178	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—malignant glioma	4.27e-05	0.000171	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BCHE—malignant glioma	4.17e-05	0.000167	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.11e-05	0.000165	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—malignant glioma	4.09e-05	0.000163	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—malignant glioma	4.08e-05	0.000163	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—malignant glioma	3.86e-05	0.000154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—malignant glioma	3.84e-05	0.000154	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—malignant glioma	3.77e-05	0.000151	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—malignant glioma	3.47e-05	0.000139	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—malignant glioma	3.43e-05	0.000137	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—malignant glioma	3.4e-05	0.000136	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—malignant glioma	3.31e-05	0.000133	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CAT—malignant glioma	3.22e-05	0.000129	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—malignant glioma	3.19e-05	0.000128	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—malignant glioma	3.12e-05	0.000125	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOR1—malignant glioma	3.05e-05	0.000122	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—malignant glioma	2.95e-05	0.000118	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—malignant glioma	2.71e-05	0.000108	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—malignant glioma	2.62e-05	0.000105	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CAV1—malignant glioma	2.48e-05	9.93e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.26e-05	9.04e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—malignant glioma	2.21e-05	8.85e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—malignant glioma	2.18e-05	8.73e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.99e-05	7.95e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.73e-05	6.93e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—malignant glioma	1.72e-05	6.87e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—malignant glioma	1.5e-05	5.99e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.06e-05	4.22e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—malignant glioma	8.63e-06	3.45e-05	CbGpPWpGaD
